Cherokee Insurance Co Purchases 7,000 Shares of Eastman Chemical Company $EMN

Cherokee Insurance Co raised its position in Eastman Chemical Company (NYSE:EMN) by 10.7% during the third quarter, Holdings Channel.com reports. The institutional investor owned 72,300 shares of the basic materials company’s stock after purchasing an additional 7,000 shares during the quarter. Eastman Chemical accounts for 2.0% of Cherokee Insurance Co’s investment portfolio, making the stock its 15th largest holding. Cherokee Insurance Co’s holdings in Eastman Chemical were worth $4,559,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Amalgamated Bank boosted its holdings in shares of Eastman Chemical by 0.8% in the 2nd quarter. Amalgamated Bank now owns 22,291 shares of the basic materials company’s stock worth $1,664,000 after acquiring an additional 168 shares in the last quarter. NewEdge Advisors LLC raised its position in Eastman Chemical by 2.6% in the 1st quarter. NewEdge Advisors LLC now owns 7,310 shares of the basic materials company’s stock valued at $644,000 after purchasing an additional 183 shares during the last quarter. Concorde Financial Corp boosted its stake in Eastman Chemical by 0.9% in the second quarter. Concorde Financial Corp now owns 22,561 shares of the basic materials company’s stock worth $1,684,000 after purchasing an additional 211 shares in the last quarter. Aldebaran Financial Inc. increased its stake in shares of Eastman Chemical by 3.0% in the second quarter. Aldebaran Financial Inc. now owns 7,887 shares of the basic materials company’s stock valued at $589,000 after buying an additional 226 shares in the last quarter. Finally, Y.D. More Investments Ltd lifted its position in Eastman Chemical by 24.8% during the 2nd quarter. Y.D. More Investments Ltd now owns 1,303 shares of the basic materials company’s stock worth $99,000 after buying an additional 259 shares in the last quarter. Institutional investors and hedge funds own 83.65% of the company’s stock.

Eastman Chemical Stock Performance

Shares of NYSE:EMN opened at $79.97 on Friday. The firm’s 50 day simple moving average is $68.40 and its 200 day simple moving average is $65.10. Eastman Chemical Company has a fifty-two week low of $56.11 and a fifty-two week high of $103.82. The company has a market capitalization of $9.12 billion, a price-to-earnings ratio of 19.55, a P/E/G ratio of 1.76 and a beta of 1.23. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.76 and a quick ratio of 0.86.

Eastman Chemical (NYSE:EMN) last issued its earnings results on Thursday, January 29th. The basic materials company reported $0.75 EPS for the quarter, missing the consensus estimate of $0.76 by ($0.01). The firm had revenue of $1.97 billion during the quarter, compared to the consensus estimate of $2.03 billion. Eastman Chemical had a net margin of 5.42% and a return on equity of 10.63%. The firm’s revenue for the quarter was down 12.1% on a year-over-year basis. During the same period in the previous year, the company posted $1.87 EPS. As a group, sell-side analysts forecast that Eastman Chemical Company will post 8.55 earnings per share for the current year.

Eastman Chemical Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 8th. Shareholders of record on Friday, March 13th will be paid a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a yield of 4.2%. The ex-dividend date of this dividend is Friday, March 13th. Eastman Chemical’s payout ratio is presently 82.15%.

Analyst Ratings Changes

EMN has been the topic of a number of research reports. JPMorgan Chase & Co. upped their target price on shares of Eastman Chemical from $60.00 to $70.00 and gave the stock an “overweight” rating in a research report on Monday, February 2nd. Weiss Ratings lowered Eastman Chemical from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, February 4th. Evercore dropped their target price on Eastman Chemical from $75.00 to $70.00 and set an “in-line” rating for the company in a research report on Tuesday, November 11th. Wells Fargo & Company reiterated an “equal weight” rating and issued a $70.00 price target on shares of Eastman Chemical in a report on Friday, December 19th. Finally, Bank of America upped their target price on shares of Eastman Chemical from $74.00 to $79.00 and gave the company a “buy” rating in a research report on Monday, February 2nd. Seven equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $78.86.

More Eastman Chemical News

Here are the key news stories impacting Eastman Chemical this week:

• Positive Sentiment: Board announced a quarterly dividend of $0.84 per share (record Mar 13, payable Apr 8), implying about a 4.2% yield — supports income investors and can underpin the share price.
• Positive Sentiment: Significant insider buying: multiple executives (including CEO Mark Costa) purchased shares in the past six months, which investors often read as management confidence in the business.
• Positive Sentiment: Large institutional buying: BlackRock added ~5.75M shares (+72%) in Q4 2025 — heavy buying from a major fund can provide price support and liquidity.
• Neutral Sentiment: Analyst coverage is mixed-but-tilted-positive: several firms carry Buy/Overweight ratings (KeyBanc, Citi, UBS, Wells Fargo), but price targets vary and the median target (~$72.50) is below recent trading levels, signalling differing views on near-term upside/ downside.
• Negative Sentiment: Q4 2025 results were weak: revenue $1.97B (down ~12% YoY), gross profit and operating profit plunged, net income fell ~68% YoY and diluted EPS declined ~67% YoY to $0.92. Cash and cash equivalents declined ~32% YoY to $566M. These marked declines help explain downside pressure on the stock. Q4 2025 Earnings
• Negative Sentiment: Zacks Research has trimmed multiple near‑term and multi‑year EPS forecasts (FY2026 cut to $5.89, FY2027 to $6.73) and reduced several quarterly estimates — lowers Street expectations and could lead to renewed analyst target/ guidance pressure.

About Eastman Chemical

Eastman Chemical Company (NYSE: EMN) is a global specialty materials company that develops, manufactures and markets a broad range of advanced materials, chemicals and fibers. Its product portfolio spans performance additives, functional products, and engineered plastics designed to enhance the durability, appearance and performance of end products across diverse industries.

The company’s main business activities include the production of specialty chemicals used in adhesives, coatings, building materials and consumer care applications, as well as high-performance plastics for packaging, automotive and electronics markets.